La-related protein 4B maintains murine MLL-AF9 leukemia stem cell self-renewal by regulating cell cycle progression

Experimental Hematology

Volumn 43, Issue 4, 2015, Pages 309-318.e2

  Zhang, Yingchi ^a,b   Peng, Luyun ^a,b   Hu, Tianyuan ^a,b   Wan, Yang ^a,b   Ren, Yuanyuan ^a,b   Zhang, Jingliao ^a,b   Wang, Xiaojuan ^a,b   Zhou, Yuan ^a,b   Yuan, Weiping ^a,b   Wang, Qianfei ^c   Cheng, Tao ^a,b   Zhu, Xiaofan ^a,b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CELL PROTEIN; LA RELATED PROTEIN 4B; PROTEIN P16; PROTEIN P19; PROTEIN P21; UNCLASSIFIED DRUG; AUTOANTIGEN; RIBONUCLEOPROTEIN; SS-B ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW; CANCER STEM CELL; CANCER SURVIVAL; CELL CYCLE PROGRESSION; CELL RENEWAL; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE SEQUENCE; GENOME; HUMAN; LEUKEMIA CELL; LEUKEMIA STEM CELL; MLL AF9 CELL LINE; MONOZYGOTIC TWINS; MOUSE; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA PURIFICATION; SPLEEN; ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL; CELL CYCLE; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

MURINAE; MUS;

ANIMALS; AUTOANTIGENS; CELL CYCLE; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; NEOPLASTIC STEM CELLS; RIBONUCLEOPROTEINS;

EID: 84925247084     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.12.003     Document Type: Article

References (30)

1. Bullinger L., Dohner K., Bair E., et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. NEngl J Med 2004, 350:1605-1616.
2. Figueroa M.E., Lugthart S., Li Y., et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010, 17:13-27.
3. Valk P.J., Verhaak R.G., Beijen M.A., et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004, 350:1617-1628.
4. Krivtsov A.V., Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007, 7:823-833.
5. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
6. Goardon N., Marchi E., Atzberger A., et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 2011, 19:138-152.
7. Shih A.H., Abdel-Wahab O., Patel J.P., Levine R.L. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012, 12:599-612.
8. Lavau C., Luo R.T., Du C., Thirman M.J. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci U S A 2000, 97:10984-10989.
9. Cozzio A., Passegue E., Ayton P.M., et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003, 17:3029-3035.
10. Krivtsov A.V., Twomey D., Feng Z., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006, 442:818-822.
11. Somervaille T.C., Cleary M.L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006, 10:257-268.
12. Zuber J., Radtke I., Pardee T.S., et al. Mouse models of human AML accurately predict chemotherapy response. Genes Dev 2009, 23:877-889.
13. Falini B., Mecucci C., Tiacci E., et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005, 352:254-266.
14. Pabst T., Mueller B.U., Zhang P., et al. Dominant-negative mutations ofCEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001, 27:263-270.
15. Frohling S., Schlenk R.F., Stolze I., et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: Prognostic relevance and analysis of cooperating mutations. J Clin Oncol 2004, 22:624-633.
16. Preudhomme C., Sagot C., Boissel N., et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: A study from the Acute Leukemia French Association (ALFA). Blood 2002, 100:2717-2723.
17. Dufour A., Schneider F., Metzeler K.H., et al. Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. JClin Oncol 2010, 28:570-577.
18. Vardiman J.W. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms. Chem Biol Interact 2010, 184:16-20.
19. Zhu X., He F., Zeng H., et al. Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet 2014, 46:287-293.
20. Bayfield M.A., Kaiser T.E., Intine R.V., Maraia R.J. Conservation of a masked nuclear export activity of La proteins and its effects on tRNA maturation. Mol Cell Biol 2007, 27:3303-3312.
21. Bousquet-Antonelli C., Deragon J.M. A comprehensive analysis of the La-motif protein superfamily. RNA 2009, 15:750-764.
22. Schaffler K., Schulz K., Hirmer A., et al. A stimulatory role for the La-related protein 4B in translation. RNA 2010, 16:1488-1499.
23. Hu X., Shen H., Tian C., et al. Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model. Blood 2009, 114:3783-3792.
24. Wang J., Sun Q., Morita Y., et al. A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell 2012, 148:1001-1014.
25. Spangrude G.J. Enrichment of murine haemopoietic stem cells: Diverging roads. Immunol Today 1989, 10:344-350.
26. Wang Y., Krivtsov A.V., Sinha A.U., et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010, 327:1650-1653.
27. Cheng T., Rodrigues N., Shen H., et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000, 287:1804-1808.
28. Viale A., De Franco F., Orleth A., et al. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 2009, 457:51-56.
29. Roe J.S., Vakoc C.R. C/EBPalpha: Critical at the origin of leukemic transformation. J Exp Med 2009, 211:1-4.
30. Wang X., Scott E., Sawyers C.L., Friedman A.D. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood 1999, 94:560-571.